piracetam has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 4 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miyazaki, I | 1 |
Murakami, S | 1 |
Torigoe, N | 1 |
Kitamura, Y | 1 |
Asanuma, M | 1 |
Ukai, K | 1 |
Fujishiro, H | 1 |
Watanabe, M | 1 |
Kosaka, K | 1 |
Ozaki, N | 1 |
Gudasheva, TA | 1 |
Koliasnikova, KN | 1 |
Antipova, TA | 1 |
Seredenin, SB | 1 |
Hill, MP | 1 |
Bezard, E | 1 |
McGuire, SG | 1 |
Crossman, AR | 1 |
Brotchie, JM | 1 |
Michel, A | 1 |
Grimée, R | 1 |
Klitgaard, H | 1 |
4 other studies available for piracetam and Autosomal Dominant Juvenile Parkinson Disease
Article | Year |
---|---|
Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice.
Topics: Amino Acid Transport System y+; Animals; Astrocytes; Cells, Cultured; Drug Delivery Systems; Female; | 2016 |
Similarity of symptoms between transient epileptic amnesia and Lewy body disease.
Topics: 3-Iodobenzylguanidine; Aged; Amnesia; Anticonvulsants; Cognition Disorders; Electroencephalography; | 2017 |
Neuropeptide cycloprolylglycine increases the levels of brain-derived neurotrophic factor in neuronal cells.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cell Line; Dose-Response Relationship, Drug; Drug Evalua | 2016 |
Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anticonvulsants; Antiparkinson Agents; Callit | 2003 |